Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Asset Writedowns and Impairment: 2014-2024

Historic Asset Writedowns and Impairment for Fortress Biotech (FBIO) over the last 8 years, with Dec 2024 value amounting to $3.7 million.

  • Fortress Biotech's Asset Writedowns and Impairment was N/A to $76,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $873,000, marking a year-over-year change of. This contributed to the annual value of $3.7 million for FY2024, which is 17.47% up from last year.
  • Per Fortress Biotech's latest filing, its Asset Writedowns and Impairment stood at $3.7 million for FY2024, which was up 17.47% from $3.1 million recorded in FY2023.
  • Fortress Biotech's Asset Writedowns and Impairment's 5-year high stood at $3.7 million during FY2024, with a 5-year trough of $48,000 in FY2021.
  • For the 3-year period, Fortress Biotech's Asset Writedowns and Impairment averaged around $2.4 million, with its median value being $3.1 million (2023).
  • In the last 5 years, Fortress Biotech's Asset Writedowns and Impairment crashed by 51.00% in 2020 and then soared by 1,006.69% in 2023.
  • Fortress Biotech's Asset Writedowns and Impairment (Yearly) stood at $49,000 in 2020, then dropped by 2.04% to $48,000 in 2021, then surged by 491.67% to $284,000 in 2022, then spiked by 1,006.69% to $3.1 million in 2023, then grew by 17.47% to $3.7 million in 2024.